Covid-19: After Oxford vaccine, expert panel recommends conditional nod to Bharat Biotech’s Covaxin

Coronavirus vaccine update: After giving its approval to Oxford-AstraZeneca Covid-19 vaccine, the subject expert committee of the Central Drugs Standard Control Organisation(CDSCO) on Saturday gave its nod for Covaxin for the emergence use. According to sources, the panel recommends granting approval for restricted emergency use of Bharat Biotech’s indigenous COVID vaccine Covaxin in India, news … Read more

Serum Institute of India to make 300 million vaccine doses by July

covid 19 vaccines 7

SII will be manufacturing around 60 million doses a month from the two plants in Pune. Serum Institute of India (SII), the world’s largest vaccine manufacturer, will be ready with 300 million doses of the Covishield Oxford-AstraZeneca Covid-19 vaccine by July 2021. Adar Poonawalla, COO, SII, said they have a stockpile of 40-50 million doses … Read more

AstraZeneca COVID Vaccine Effective in Late Trials

By Robert PreidtHealthDay Reporter TUESDAY, Dec. 8, 2020 (HealthDay News) — AstraZeneca’s COVID-19 vaccine is safe and effective, new data from late-stage trials shows. Overall, the vaccine protected against symptomatic disease in 70% of cases, according to a team led by researchers from Oxford University in England. Among study volunteers who got a … Read more

Coronavirus vaccine update: Results show Oxford University-AstraZeneca COVID-19 vaccine can be 90% effective

vaccine 7

A volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa’s first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. (AP photo/FILE) The University of Oxford and Britain’s AstraZeneca announced on Monday that the Covid-19 … Read more

Pune: Phase 2 human trial of Oxford vaccine may start tomorrow

1 872

Those chosen for receiving a dose of vaccine will be in the age group of 18 to 99 years, he told PTI. Doses of the potential coronavirus vaccine developed by researchers at Oxford University arrived at the Bharti Vidyapeeth’s Medical College here for phase-2 human trials on Tuesday, an official said. The trial may begin … Read more